AUM Biosciences’ Asia-driven oncology therapeutics demonstrates a pioneering approach to oncology research, where demographics play a significant role in the accurate identification and treatment of cancers. Our collaboration approach is mainly driven by a goal of value creation. We walk along with our partners in realizing significant value in developing new treatment options for patients.

Our small molecule therapies, whilst harnessing the power of precision and digital medicine tools, strongly supports our ‘East-to-West’ approach. We are looking to partner and collaborate with research institutions and companies to complement our in-house expertise and experience in oncology therapy development and commercialisation.

As a disruptor in the drug development space, we believe that strong collaborations/associations with industry leaders, academicians and research experts will help us collectively work towards applying our extensive knowledge to specific intended target disease areas. Our goal is to make a difference in a cancer patient’s life by bringing our oncology therapeutics to patients and clinicians to enable better informed decisions backed by robust clinical data.

Become a part of our disruptive journey, contact us.